Annual Total Long Term Liabilities
$77.33 M
+$41.79 M+117.58%
December 31, 2024
Summary
- As of March 13, 2025, ALGS annual total long term liabilities is $77.33 million, with the most recent change of +$41.79 million (+117.58%) on December 31, 2024.
- During the last 3 years, ALGS annual total long term liabilities has risen by +$65.65 million (+562.02%).
- ALGS annual total long term liabilities is now -60.86% below its all-time high of $197.59 million, reached on December 31, 2019.
Performance
ALGS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$77.33 M
+$59.96 M+345.09%
December 31, 2024
Summary
- As of March 13, 2025, ALGS quarterly total long term liabilities is $77.33 million, with the most recent change of +$59.96 million (+345.09%) on December 31, 2024.
- Over the past year, ALGS quarterly long term liabilities has increased by +$59.96 million (+345.09%).
- ALGS quarterly long term liabilities is now -62.98% below its all-time high of $208.87 million, reached on September 30, 2020.
Performance
ALGS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ALGS Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +117.6% | +345.1% |
3 y3 years | +562.0% | +768.0% |
5 y5 years | -60.9% | +768.0% |
ALGS Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +700.2% | at high | +803.1% |
5 y | 5-year | -60.9% | +700.2% | -63.0% | +803.1% |
alltime | all time | -60.9% | +700.2% | -63.0% | +803.1% |
Aligos Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $77.33 M(+117.6%) | $77.33 M(+345.1%) |
Sep 2024 | - | $17.37 M(-3.6%) |
Jun 2024 | - | $18.02 M(-63.4%) |
Mar 2024 | - | $49.23 M(+38.5%) |
Dec 2023 | $35.54 M(+267.8%) | $35.54 M(+315.1%) |
Sep 2023 | - | $8.56 M(-7.6%) |
Jun 2023 | - | $9.27 M(+4.1%) |
Mar 2023 | - | $8.91 M(-7.8%) |
Dec 2022 | $9.66 M | $9.66 M(-16.1%) |
Sep 2022 | - | $11.52 M(-17.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $13.89 M(-14.4%) |
Mar 2022 | - | $16.23 M(+38.9%) |
Dec 2021 | $11.68 M(-22.1%) | $11.68 M(+3.6%) |
Sep 2021 | - | $11.28 M(-12.5%) |
Jun 2021 | - | $12.89 M(-8.5%) |
Mar 2021 | - | $14.09 M(-6.0%) |
Dec 2020 | $14.99 M(-92.4%) | $14.99 M(-92.8%) |
Sep 2020 | - | $208.87 M(+1739.6%) |
Jun 2020 | - | $11.35 M(-94.3%) |
Dec 2019 | $197.59 M(+73.3%) | $197.59 M |
Dec 2018 | $113.99 M | - |
FAQ
- What is Aligos Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Aligos Therapeutics?
- What is Aligos Therapeutics annual total long term liabilities year-on-year change?
- What is Aligos Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly long term liabilities year-on-year change?
What is Aligos Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ALGS is $77.33 M
What is the all time high annual total long term liabilities for Aligos Therapeutics?
Aligos Therapeutics all-time high annual total long term liabilities is $197.59 M
What is Aligos Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ALGS annual total long term liabilities has changed by +$41.79 M (+117.58%)
What is Aligos Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ALGS is $77.33 M
What is the all time high quarterly long term liabilities for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly total long term liabilities is $208.87 M
What is Aligos Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ALGS quarterly total long term liabilities has changed by +$59.96 M (+345.09%)